Financials

  • Market Capitalization 179.84 M
  • Employee 66
  • Founded 2006
  • CEO N/A
  • Website www.precisionbiosciences.com
  • Headquarter Delaware, United States
  • FIGI BBG008NSBPV3
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-1.17
주가매출액비율
1.56

Precision BioSciences, Inc. - Common Stock

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

뉴스